Prescription drug · ANDA
Silodosin NDC 71335-3128
Silodosin 8 mg/1 · Capsule · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-3128-1 | 71335312801 | 30 CAPSULE in 1 BOTTLE (71335-3128-1)Marketed from Apr 29, 2026 | |
| 71335-3128-2 | 71335312802 | 90 CAPSULE in 1 BOTTLE (71335-3128-2)Marketed from Apr 29, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Silodosin
- Generic name (nonproprietary)
- silodosin
- Active ingredients
- Silodosin — 8 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211166
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 71335-3128_88136a96-4e67-477f-8f35-d2b2f99cce08SPL ID 88136a96-4e67-477f-8f35-d2b2f99cce08SPL set ID afbf4823-8663-4152-9346-ca42c7b7d722RxCUI 809477UNII CUZ39LUY82
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335312801followed by a unit qualifier and the quantityPackage 71335-3128-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Silodosin, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [ see CLINICAL STUDIES ( 14 )]. Silodosin is not indicated for the treatment of hypertension. Silodosin, an alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Silodosin is not indicated for the treatment of hypertension ( 1 ).
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 211166
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.